Contents

#### **Preface X**II**I**

**Section 1 Lipoprotein Structure and Assembly 1**  Chapter 1 **Lipoprotein Structure and Dynamics: Low Density Lipoprotein Viewed as a Highly Dynamic and Flexible Nanoparticle 3**  Ruth Prassl and Peter Laggner Chapter 2 **New Insights into the Assembly and Metabolism of ApoB-Containing Lipoproteins from** *in vivo* **Kinetic Studies: Results on Healthy Subjects and Patients with Chronic Kidney Disease 21**  Benjamin Dieplinger and Hans Dieplinger **Section 2 Diagnosis of Lipoprotein Disorders 45**  Chapter 3 **The Importance of Lipid and Lipoprote in Ratios in Interpretetions of Hyperlipidaemia of Pregnancy 47**  D.S. Mshelia and A.A. Kullima Chapter 4 **A Non-Atherogenic and Atherogenic Lipoprotein Profile in Individuals with Dyslipoproteinemia 73**  Stanislav Oravec, Johannes Mikl, Kristina Gruber and Elisabeth Dostal Chapter 5 **The apoB/apoA-I Ratio is a Strong Predictor of Cardiovascular Risk 95**  Göran Walldius Chapter 6 **Approaches to Access Biological Data Sources 149**  Assia Rharbi, Khadija Amine, Zohra Bakkoury, Afaf Mikou, Anass Kettani andAbdelkader Betari

#### X Contents


Chapter 18 **HDL-Associated Paraoxonase 1 Gene Polymorphisms as a Genetic Markers for Wide Spread Diseases 431**  Ivana Pejin-Grubiša

VI Contents

**Section 3 Hyper- and Dyslipoproteinemias 171** 

**Increasing Cardiovascular Mortality 173** 

Chapter 8 **Lipoproteins and Cardiovascular Diseases 197**  Adebowale Saba and Olayinka Oridupa

Chapter 9 **Linking the Pathobiology of Hypercholesterolemia** 

**Section 4 Management of Hyper and Dyslipoproteinemias 253** 

**on Response to Chemotherapy and Hormone** 

Karl-Erik Eilertsen, Rune Larsen, Hanne K. Mæhre,

Chapter 15 **Lipoproteins and Apolipoproteins of the Ageing Eye 355** 

Vikram Jairam, Koji Uchida and Vasanthy Narayanaswami

**Introduction and Biological Significance 409**  Mohammad Z. Ashraf and Swati Srivastava

**Regulation Altering Long-Term Cognition Outcomes 255** 

**of Taurine Supplementation is Model Dependent 269** 

Eduardo Guimarães Hourneaux de Moura, Ivan Roberto Bonotto Orso, Bruno da Costa Martins and Guilherme Sauniti Lopes

Somayeh Hosseinpour-Niazi, Parvin Mirmiran and Fereidoun Azizi

Xiaoyan Zhang and Hainsworth Y. Shin

Chapter 10 **The Confounding Factor of Apolipoprotein E** 

Chapter 11 **Anticholesterolemic and Antiatherogenic Effects** 

Ida-Johanne Jensen and Edel O. Elvevoll

Chapter 13 **Nutritional Management of Disturbances in Lipoprotein Concentrations 303**

Chapter 14 **Cyclosporin A-Induced Hyperlipidemia 337**  Maaike Kockx and Leonard Kritharides

**Section 5 Lipid Oxidation and Anti-Oxidants 381** 

Chapter 16 **Pathophysiology of Lipoprotein Oxidation 383** 

Edward Loane

Chapter 17 **Oxidized Phospholipids:**

Chapter 12 **Endoscopic Treatment of Metabolic Syndrome 289** 

Summer F. Acevedo

**with the Neutrophil Mechanotransduction 223** 

Jelena Umbrasiene, Ruta-Marija Babarskiene and Jone Vencloviene

Chapter 7 **Lipoproteins Impact** 

	- **Section 9 Lipoproteins in Inflammatory and Infectious Diseases 675**
